Calendar Abbott Laboratories Swiss Exchange
Stocks
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 77.50 CHF | +1.97% |
|
+3.33% | -21.72% |
| 07-06 | Evercore ISI Adjusts Abbott Laboratories Price Target to $112 From $120 | MT |
| 07-02 | Missouri jury sides with Enfamil maker Mead Johnson in case over preterm baby formula | RE |
Chart calendar Abbott Laboratories
Upcoming events on Abbott Laboratories
| 2026-07-15 | Ex-dividend date - 0.63 USD | 00:00 |
| 2026-07-16 | Earnings release - Q2 2026 | |
| 2026-07-16 | Earnings presentation | 09:00 |
Past events on Abbott Laboratories
| 2026-04-24 | Présentation aux Actionnaires / Analystes | 09:00 |
| 2026-04-24 | Annual General Meeting | 09:00 |
| 2026-04-16 | Earnings release - Q1 2026 | |
| 2026-04-16 | Earnings presentation | 09:00 |
| 2026-01-22 | Earnings release - Q4 2025 | |
| 2026-01-22 | Earnings presentation | 09:00 |
| 2025-10-15 | Earnings presentation | 09:00 |
| 2025-10-15 | Earnings release - Q3 2025 | |
| 2025-07-17 | Earnings release - Q2 2025 | |
| 2025-07-17 | Earnings presentation | 09:00 |
Past dividends on Abbott Laboratories
| 2026-04-15 | Ex-dividend date - 0.63 USD | 00:00 |
| 2026-01-15 | Ex-dividend date - 0.63 USD | 00:00 |
| 2025-10-15 | Ex-dividend date - 0.59 USD | 00:00 |
| 2025-07-15 | Ex-dividend date - 0.59 USD | 00:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 40 109 40 077 0.08% | 41 950 41 988 -0.09% | 44 328 44 675 -0.78% | 50 256 | 54 748 | 58 610 |
|
EBITDA Million USD | Released Forecast Spread | 10 188 10 191 -0.03% | 10 635 10 653 -0.17% | 11 735 11 873 -1.17% | 13 414 | 14 578 | 15 961 |
|
EBIT Million USD | Released Forecast Spread | 8 911 8 883 0.32% | 9 295 9 341 -0.49% | 10 301 10 372 -0.69% | 11 665 | 13 038 | 14 362 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 6 664 6 563 1.54% | 7 013 7 271 -3.55% | 8 466 8 669 -2.35% | 8 467 | 10 410 | 11 700 |
|
Net income Million USD | Released Forecast Spread | 5 723 5 652 1.26% | 13 402 5 934 125.87% | 6 524 6 923 -5.77% | 7 018 | 8 389 | 9 226 |
|
EPS USD | Released Forecast Spread | 3,26 3,23 0.81% | 7,64 3,42 123.37% | 3,72 3,98 -6.46% | 4,04 | 4,74 | 5,44 |
| Announcement Date | 24/01/24 | 22/01/25 | 22/01/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 | 2028 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 10 635 10 551 0.8% | 10 974 11 031 -0.52% | 10 358 10 417 -0.57% | 11 142 11 058 0.76% | 11 369 11 393 -0.21% | 11 459 11 802 -2.91% | 11 164 10 998 1.51% | 12 517 | 13 124 | 13 554 | 12 773 | 13 494 | 14 093 | 14 526 | 13 939 |
|
EBITDA Million USD | Released Forecast Spread | 2 730 2 763 -1.19% | 3 006 3 069 -2.04% | 2 514 2 474 1.63% | 2 908 2 842 2.34% | 2 981 3 035 -1.78% | 3 332 3 423 -2.67% | 2 655 2 648 0.26% | 3 252 | 3 597 | 3 982 | 3 078 | 3 394 | 3 725 | 4 016 | 3 712 |
|
EBIT Million USD | Released Forecast Spread | 2 399 2 412 -0.56% | 2 664 2 710 -1.7% | 2 178 2 161 0.78% | 2 551 2 551 -0% | 2 610 2 642 -1.2% | 2 962 3 037 -2.46% | 2 274 2 268 0.28% | 2 795 | 3 093 | 3 503 | 2 759 | 3 084 | 3 399 | 3 741 | 3 233 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 940 1 893 2.51% | 2 030 2 082 -2.47% | 1 778 1 643 8.25% | 2 150 2 150 0% | 2 180 2 155 1.14% | 2 358 2 406 -2% | 1 449 1 852 -21.75% | 2 031 | 2 313 | 2 675 | 2 199 | 2 479 | 2 688 | 3 044 | 2 534 |
|
Net income Million USD | Released Forecast Spread | 1 646 1 559 5.55% | 9 229 1 807 410.6% | 1 325 1 359 -2.49% | 1 779 1 762 0.98% | 1 644 1 828 -10.08% | 1 776 2 104 -15.59% | 1 077 1 510 -28.66% | 1 648 | 1 895 | 2 233 | 1 728 | 1 946 | 2 200 | 2 501 | 2 220 |
|
EPS USD | Released Forecast Spread | 0,94 0,89 5.33% | 5,27 1,05 404.2% | 0,76 0,78 -2.59% | 1,01 0,99 1.86% | 0,94 1,04 -9.72% | 1,01 1,21 -16.48% | 0,61 0,87 -29.77% | 0,97 | 1,11 | 1,31 | 0,96 | 1,15 | 1,30 | 1,47 | 1,28 |
| Announcement Date | 16/10/24 | 22/01/25 | 16/04/25 | 17/07/25 | 15/10/25 | 22/01/26 | 16/04/26 | - | - | - | - | - | - | - | - |
| 2026-07-14 |  | Earnings release - Q2 2026 | |
| 2026-07-14 | | Earnings release - Q2 2026 | |
| 2026-07-14 | | Earnings presentation | 08:00 |
| 2026-07-14 | | Earnings release - Q2 2026 | 01:00 |
| 2026-07-14 | | Earnings presentation | 02:00 |
| 2026-07-14 | | Earnings presentation | 08:00 |
| 2026-07-14 | | Earnings release - Q4 2026 | |
| 2026-07-15 | | Earnings presentation | 03:30 |
| 2026-07-15 | | Earnings release - Q3 2026 | |
| 2026-07-16 | | Earnings release - Q2 2026 |
Past sector events for Abbott Laboratories
| 2026-07-03 | | Ex-dividend date for special dividend - 1.7 CHF | 00:00 |
| 2026-07-03 | | Ex-dividend date - 2.7 CHF | 00:00 |
| 2026-07-01 | | Annual General Meeting | 04:00 |
| 2026-07-01 | | Extraordinary General Meeting | 02:30 |
| 2026-07-01 | | Ex-dividend date - 0.1 CNY | 00:00 |
| 2026-06-29 | | Earnings release - Annual 2025 | |
| 2026-06-29 | | Earnings presentation | 09:00 |
| 2026-06-26 | | Ex-dividend date - 0.72 USD | 00:00 |
| 2026-06-26 | | Ex-dividend date - 0.16275 CNY | 00:00 |
| 2026-06-26 | | Annual General Meeting | 01:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
- Calendar Abbott Laboratories
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
